Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Bijal Shah"'
Autor:
Ning Dong, Hailing Zhang, Jinming Song, Jamila Mammadova, Bijal Shah, Hayder Saeed, Sameh Gaballa, Ariel Grajales‐Cruz, Leidy Isenalumhe, Celeste Bello, Lubomir Sokol, Javier Pinilla, Julio Chavez
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 285-289 (2024)
Externí odkaz:
https://doaj.org/article/7e886c7b78ca4f12901fa86b3dd39ce3
Autor:
Aref Al‐Kali, Ibrahim Aldoss, Pamela J. Atherton, Carrie A. Strand, Bijal Shah, Jonathan Webster, Bhavana Bhatnagar, Karen S. Flatten, Kevin L. Peterson, Paula A. Schneider, Sarah A. Buhrow, Jianping Kong, Joel M. Reid, Alex A. Adjei, Scott H. Kaufmann
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21229-21239 (2023)
Abstract Background Despite recent approval of several new agents, relapsed acute lymphoblastic leukemia (ALL) remains challenging to treat. Sapanisertib (MLN0128/TAK‐228) is an oral TORC1/2 inhibitor that exhibited preclinical activity against ALL
Externí odkaz:
https://doaj.org/article/55ca42b54be149f0b8acb389ece68dc9
Autor:
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D. Jain, Rahul Mhaskar, Kayla Reid, Sae Bom Lee, Salvatore Corallo, Melanie J. Hidalgo-Vargas, Abhishek Kumar, Julio Chavez, Bijal Shah, Aleksandr Lazaryan, Farhad Khimani, Taiga Nishihori, Christina Bachmeier, Rawan Faramand, Michael G. Fradley, Daniel Jeong, Guilherme H. Oliveira, Frederick L. Locke, Marco L Davila, Mohammed Alomar
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and c
Externí odkaz:
https://doaj.org/article/2b3320c84568447e825867b260a94475
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-10 (2023)
Abstract CAR-T cells are widely recognized for their potential to successfully treat hematologic cancers and provide durable response. However, severe adverse events such as cytokine release syndrome (CRS) and neurotoxicity are concerning. Our goal i
Externí odkaz:
https://doaj.org/article/bc11f9c5d417482aa163c574c355e2e3
Autor:
Claire Roddie, Karamjeet Sandhu, Eleni Tholouli, Paul Shaughnessy, Pere Barba Suñol, Manuel Nuno Direito de Morais Guerreiro, Mehrdad Abedi, Michael Bishop, Jean Yared, Armin Ghobadi, Deborah Yallop, Aaron Logan, Beitinjaneh Amer, Jeremy Pantin, Martha L Arellano, Sridhar Chaganti, Ram Malladi, Tobias Menne, Virginia Escamilla, Katharine Hodby, Krishna Gundabolu, Luke Mountjoy, Kristen Odwyer, Sameem Abedin, Hassan Alkhateeb, Bijal Shah, Silvia Basilico, Deborah Cluxton, Joanna Dawes, Pierre Lao-Sirieix, Meera Raymond, Justin Shang, Yanqing Hu, Gianfranco Pittari, Kapil Saxena, Wolfram Brugger, Y Zhang, Martin Pule, Daniel Park, Daniel De Angelo, Elias Jabbour
Publikováno v:
HemaSphere, Vol 7, p e998506d (2023)
Externí odkaz:
https://doaj.org/article/847828f94a674a0c9263a5a47141ff67
Autor:
Bijal Shah, Ryan D. Cassaday, Jae H. Park, Roche Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Kristen M. O’dwyer, Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick Stiff, Lang Zhou, Tsveta Hadjivassileva, Rita Damico Khalid, Armin Ghobadi
Publikováno v:
HemaSphere, Vol 7, p e54499e3 (2023)
Externí odkaz:
https://doaj.org/article/7aed547152154c0faf9b4f2f5e348358
Publikováno v:
HemaSphere, Vol 7, p e22348b6 (2023)
Externí odkaz:
https://doaj.org/article/a1d964ac323b492dbb77da32db36ba81
Autor:
Mohammad Ammad Ud Din, Nayeon Oh, Aliyah Baluch, Olga Klinkova, Rod Quilitz, Melissa Alsina, Nelli Bejanyan, Omar Castaneda, Julio Chavez, Hany Elmariah, Ciara Freeman, Doris Hansen, Michael Jain, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Asmita Mishra, Leonel Ochoa, Lia Perez, Joseph Pidala, Bijal Shah, Taiga Nishihori, Frederick Locke, Rawan Faramand
Publikováno v:
HemaSphere, Vol 7, p e971246c (2023)
Externí odkaz:
https://doaj.org/article/f564b9060c574acab7f765ec7c3cd8b1
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
The potential of chimeric antigen receptor (CAR) T cells to successfully treat hematological cancers is widely recognized. Multiple CAR-T cell therapies are currently under clinical development, with most in early stage, during which dose selection i
Externí odkaz:
https://doaj.org/article/a995f695359c4c84a198dd6a34b4b3b3
Autor:
Ling Zhang, Bijal Shah, Yumeng Zhang, Hammad Tashkandi, Wenbin Xiao, Sebastian Fernandez-Pol, Maria Vergara-Lluri, Mohammad Hussaini, Jinming Song, Jeffrey Lancet, Lynn Moscinski, Seongseok Yun, Chuanyi M. Lu, L. Jeffrey Medeiros, Guilin Tang
Publikováno v:
Human Pathology. 136:1-15